Pictet North America Advisors’s Gilead Sciences GILD Stock Holding History

Pictet North America Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-145,644	Closed	-$12.2M	–	107
2016 Q2	$12.2M	Sell	145,644 -31,704	-18%	-$2.81M	2.83%	11
2016 Q1	$16.3M	Sell	177,348 -2,428	-1%	-$219K	3.41%	9
2015 Q4	$18.2M	Buy	179,776 +157,852	+720%	+$16.4M	4.25%	7
2015 Q3	$2.15M	Buy	+21,924	New	+$2.43M	0.6%	19

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet North America Advisors's GILD Position: Q3 2016 in Review

Pictet North America Advisors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 145,644 shares — an estimated $12.2M sold.

Pictet North America Advisors first reported a position in GILD in Q3 2015 and held it in 4 quarters. The position peaked at $18.2M in Q4 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Pictet North America Advisors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Pictet North America Advisors sold 145,644 Gilead Sciences shares in Q3 2016, an estimated $12.2M.
Pictet North America Advisors first reported a position in Gilead Sciences in Q3 2015 and held it in 4 quarters.
Pictet North America Advisors's Gilead Sciences position peaked at $18.2M in Q4 2015.
1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Pictet North America Advisors's 13F filing for Q3 2016, filed 7 Nov 2016.